Table 3.
Predictors analysis of readmission
| Variable | β | S.E | Wald | P | OR | 95% CI | |
|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||
| Intercept | − 2.374 | 0.753 | 9.942 | 0.002 | |||
| Age | − 0.008 | 0.011 | 0.491 | 0.484 | 0.992 | 0.972 | 1.014 |
| Gender | |||||||
| Male | Ref | ||||||
| Female | − 0.216 | 0.208 | 1.076 | 0.299 | 0.806 | 0.535 | 1.212 |
| Acute exacerbation in previous 1 year | |||||||
| No | Ref | ||||||
| Yes | 1.408 | 0.207 | 46.174 | < 0.001 | 4.086 | 2.723 | 6.133 |
| LABA | |||||||
| No | Ref | ||||||
| Yes | 1.515 | 0.537 | 7.951 | 0.005 | 4.550 | 1.587 | 13.042 |
| ICS | |||||||
| No | Ref | ||||||
| Yes | − 1.484 | 0.555 | 7.157 | 0.007 | 0.227 | 0.076 | 0.672 |
| ALT | − 0.015 | 0.007 | 4.152 | 0.042 | 0.985 | 0.971 | 0.999 |
| CAT Score | 0.087 | 0.021 | 17.871 | < 0.001 | 1.091 | 1.048 | 1.136 |
LABA long-acting β agonist, ICS inhaled corticosteroids, ALT glutamic-pyruvic transaminase, CAT COPD assessment test